169 related articles for article (PubMed ID: 35024656)
1. Prevalence and disease progression of genetically-confirmed facioscapulohumeral muscular dystrophy type 1 (FSHD1) in China between 2001 and 2020: a nationwide population-based study.
Wang Z; Qiu L; Lin M; Chen L; Zheng F; Lin L; Lin F; Ye Z; Lin X; He J; Wang L; Lin X; He Q; Chen W; Lin Y; Fu Y; Wang N
Lancet Reg Health West Pac; 2022 Jan; 18():100323. PubMed ID: 35024656
[TBL] [Abstract][Full Text] [Related]
2. Association of 4qA-Specific Distal D4Z4 Hypomethylation With Disease Severity and Progression in Facioscapulohumeral Muscular Dystrophy.
Zheng F; Qiu L; Chen L; Zheng Y; Lin X; He J; Lin X; He Q; Lin Y; Lin L; Wang L; Lin F; Yang K; Lin M; Lin Y; Fu Y; Wang N; Wang Z
Neurology; 2023 Jul; 101(3):e225-e237. PubMed ID: 37225433
[TBL] [Abstract][Full Text] [Related]
3. Identifying diagnostic DNA methylation profiles for facioscapulohumeral muscular dystrophy in blood and saliva using bisulfite sequencing.
Jones TI; Yan C; Sapp PC; McKenna-Yasek D; Kang PB; Quinn C; Salameh JS; King OD; Jones PL
Clin Epigenetics; 2014; 6(1):23. PubMed ID: 25400706
[TBL] [Abstract][Full Text] [Related]
4. Case report: Identification of facioscapulohumeral muscular dystrophy 1 in two siblings with normal phenotypic parents using optical genome mapping.
Jiang J; Cai X; Qu H; Yao Q; He T; Yang M; Zhou H; Zhang X
Front Neurol; 2024; 15():1258831. PubMed ID: 38361638
[TBL] [Abstract][Full Text] [Related]
5. CLIA Laboratory Testing for Facioscapulohumeral Dystrophy: A Retrospective Analysis.
Rieken A; Bossler AD; Mathews KD; Moore SA
Neurology; 2021 Feb; 96(7):e1054-e1062. PubMed ID: 33443126
[TBL] [Abstract][Full Text] [Related]
6. Genotype and phenotype analysis of 43 Iranian facioscapulohumeral muscular dystrophy patients; Evidence for anticipation.
Alavi A; Esmaeili S; Nafissi S; Kahrizi K; Najmabadi H
Neuromuscul Disord; 2018 Apr; 28(4):303-314. PubMed ID: 29402602
[TBL] [Abstract][Full Text] [Related]
7. [Clinical and molecular diagnosis of facioscapulohumeral dystrophy type 1 (FSHD1) in 2012].
Salort-Campana E; Nguyen K; Lévy N; Pouget J; Attarian S
Rev Neurol (Paris); 2013; 169(8-9):573-82. PubMed ID: 24011979
[TBL] [Abstract][Full Text] [Related]
8. Facioscapulohumeral muscular dystrophy 1 patients participating in the UK FSHD registry can be subdivided into 4 patterns of self-reported symptoms.
Banerji CRS; Cammish P; Evangelista T; Zammit PS; Straub V; Marini-Bettolo C
Neuromuscul Disord; 2020 Apr; 30(4):315-328. PubMed ID: 32327287
[TBL] [Abstract][Full Text] [Related]
9. [Facioscapulohumeral muscular dystrophy type 2].
Sacconi S; Desnuelle C
Rev Neurol (Paris); 2013; 169(8-9):564-72. PubMed ID: 23969240
[TBL] [Abstract][Full Text] [Related]
10. Individual epigenetic status of the pathogenic D4Z4 macrosatellite correlates with disease in facioscapulohumeral muscular dystrophy.
Jones TI; King OD; Himeda CL; Homma S; Chen JC; Beermann ML; Yan C; Emerson CP; Miller JB; Wagner KR; Jones PL
Clin Epigenetics; 2015; 7(1):37. PubMed ID: 25904990
[TBL] [Abstract][Full Text] [Related]
11. Facioscapulohumeral muscular dystrophy.
Sacconi S; Salviati L; Desnuelle C
Biochim Biophys Acta; 2015 Apr; 1852(4):607-14. PubMed ID: 24882751
[TBL] [Abstract][Full Text] [Related]
12. FSHD1 and FSHD2 form a disease continuum.
Sacconi S; Briand-Suleau A; Gros M; Baudoin C; Lemmers RJLF; Rondeau S; Lagha N; Nigumann P; Cambieri C; Puma A; Chapon F; Stojkovic T; Vial C; Bouhour F; Cao M; Pegoraro E; Petiot P; Behin A; Marc B; Eymard B; Echaniz-Laguna A; Laforet P; Salviati L; Jeanpierre M; Cristofari G; van der Maarel SM
Neurology; 2019 May; 92(19):e2273-e2285. PubMed ID: 30979860
[TBL] [Abstract][Full Text] [Related]
13. Analyzing Copy Number Variation Using Pulsed-Field Gel Electrophoresis: Providing a Genetic Diagnosis for FSHD1.
Lemmers RJ
Methods Mol Biol; 2017; 1492():107-125. PubMed ID: 27822859
[TBL] [Abstract][Full Text] [Related]
14. Cis D4Z4 repeat duplications associated with facioscapulohumeral muscular dystrophy type 2.
Lemmers RJLF; van der Vliet PJ; Vreijling JP; Henderson D; van der Stoep N; Voermans N; van Engelen B; Baas F; Sacconi S; Tawil R; van der Maarel SM
Hum Mol Genet; 2018 Oct; 27(20):3488-3497. PubMed ID: 30281091
[TBL] [Abstract][Full Text] [Related]
15. A family-based study into penetrance in facioscapulohumeral muscular dystrophy type 1.
Wohlgemuth M; Lemmers RJ; Jonker M; van der Kooi E; Horlings CG; van Engelen BG; van der Maarel SM; Padberg GW; Voermans NC
Neurology; 2018 Jul; 91(5):e444-e454. PubMed ID: 29997197
[TBL] [Abstract][Full Text] [Related]
16. FSHD1 Diagnosis in a Russian Population Using a qPCR-Based Approach.
Zernov NV; Guskova AA; Skoblov MY
Diagnostics (Basel); 2021 May; 11(6):. PubMed ID: 34071558
[TBL] [Abstract][Full Text] [Related]
17. Facioscapulohumeral Muscular Dystrophy.
Statland JM; Tawil R
Continuum (Minneap Minn); 2016 Dec; 22(6, Muscle and Neuromuscular Junction Disorders):1916-1931. PubMed ID: 27922500
[TBL] [Abstract][Full Text] [Related]
18. Late-onset facioscapulohumeral muscular dystrophy type 1 in previously undiagnosed families: Presenting clinical features in an often-misdiagnosed disorder.
Felice KJ; Whitaker CH
Muscle Nerve; 2023 Nov; 68(5):758-762. PubMed ID: 37638785
[TBL] [Abstract][Full Text] [Related]
19. Clinical features of facioscapulohumeral muscular dystrophy 2.
de Greef JC; Lemmers RJ; Camaño P; Day JW; Sacconi S; Dunand M; van Engelen BG; Kiuru-Enari S; Padberg GW; Rosa AL; Desnuelle C; Spuler S; Tarnopolsky M; Venance SL; Frants RR; van der Maarel SM; Tawil R
Neurology; 2010 Oct; 75(17):1548-54. PubMed ID: 20975055
[TBL] [Abstract][Full Text] [Related]
20. [Clinical phenotype and genotype of early-onset facioscapulohumeral muscular dystrophy type 1].
Chen XY; Chang XZ; Fu XN; Ge L; Fan YB; Liu JY; Wang ZQ; Zhang W; Xiong H
Zhonghua Er Ke Za Zhi; 2020 May; 58(5):408-412. PubMed ID: 32392958
[No Abstract] [Full Text] [Related]
[Next] [New Search]
